US Patent 8278287 siRNA compounds for inhibiting NRF2

Patent 8278287 was granted and assigned to Quark Pharmaceuticals Inc on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82782870

Patent Inventor Names

Hagar Kalinski0

Elena Feinstein0

Igor Mett0

Date of Patent

October 2, 2012

Patent Application Number

129883070

Date Filed

April 6, 2009

Patent Citations Received

‌

US Patent 11932853 Control of insect infestation

‌

US Patent 12077763 RNA-based control of powdery mildew

Patent Primary Examiner

‌

Terra Cotta Gibbs

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8278287 siRNA compounds for inhibiting NRF2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API